Cargando…
A light-controlled multi-step drug release nanosystem targeting tumor hypoxia for synergistic cancer therapy
Hypoxia is a major obstacle for cancer therapy due to its association with cell proliferation, tumor distant metastasis, and treatment resistance. In this study, a hypoxia-activated bifunctional prodrug (CC5) was designed, synthesized and encapsulated by a photo-responsive ruthenium complex-derived...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
The Royal Society of Chemistry
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8442699/ https://www.ncbi.nlm.nih.gov/pubmed/34659720 http://dx.doi.org/10.1039/d1sc01888d |